Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 1/20 | 0.55 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.55 |
| ▸ | MDM4 | O15151 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | SLC16A3 | O15427 | 6/20 | 0.52 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8654405 | 0.86 | KCNK3 (0.57) | KCNK3KCNK9MDM4TP53HDAC3 | |
| SCHEMBL27849340 | 0.85 | KCNK3 (0.56) | KCNK3KCNK9MDM4TP53HDAC3 | |
| SCHEMBL11347943 | 0.83 | NR1H4 (0.55) | KCNK3KCNK9MDM4TP53HDAC3 | |
| SCHEMBL528445 | 0.81 | KCNK3 (0.77) | KCNK3KCNK9MDM4TP53HDAC3 | |
| SCHEMBL16532204 | 0.81 | SLC16A3 (0.61) | KCNK3KCNK9MDM4TP53HDAC3 | |
| SCHEMBL7511265 | 0.79 | HDAC3 (0.61) | KCNK3KCNK9MDM4TP53HDAC3 | |
| SCHEMBL6971074 | 0.79 | NR1H4 (0.57) | KCNK3KCNK9MDM4TP53HDAC3 | |
| SCHEMBL21711305 | 0.79 | NR1H4 (0.75) | KCNK3KCNK9MDM4TP53HDAC3 | |
| SCHEMBL8902669 | 0.79 | KCNK3 (0.57) | KCNK3KCNK9MDM4TP53HDAC3 | |
| SCHEMBL7374512 | 0.78 | KCNK3 (0.53) | KCNK3KCNK9MDM4TP53HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9735377-B2 | Phosphorescent emitters and host materials with improved stability | UNIVERSAL DISPLAY CORPORATION (US) | 2017-08-15 | — | — | US | disclosed |
| US-20170110676-A1 | PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORPORATION | 2017-04-20 | — | — | US | disclosed |
| US-20140042413-A1 | PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORPORATION (US) | 2014-02-13 | — | — | US | disclosed |
| US-8586204-B2 | Phosphorescent emitters and host materials with improved stability | UNIVERSAL DISPLAY CORPORATION (US) | 2013-11-19 | — | — | US | disclosed |
| US-20110057559-A1 | PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORPORATION (US) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110057559-A1 | PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY | DDT, TPST2, NUDT1 | KCNK3 4478/4885KCNK9 4479/4885MDM4 560/4885 |
| US-20170110676-A1 | PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY | NUDC, TEC, MAP1LC3C | KCNK3 3915/4885KCNK9 3988/4885MDM4 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.